Cardiovascular-kidney-metabolic Syndrome
📧 Sign up to get email alerts when something new happens for Cardiovascular-kidney-metabolic Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-25Clinical Trial Results: Early GLP-1 Receptor Agonist and SGLT2 Inhibitor Add-On Strategies in Adults With Obesity, Type 2 Diabetes, Cardiovascular-Kidney-Metabolic Syndrome Stage 2-3, and Metabolic Dysfunction-Associated Steatotic Liver Disease
Clinical trial results for early GLP-1 receptor agonist and SGLT2 inhibitor add-on strategies in adults with obesity, type 2 diabetes, cardi…
-
CLINICAL_TRIALS trial_result · 2026-06-22Clinical Trial Results: Early Add-On Combination of GLP-1 Receptor Agonist and SGLT2 Inhibitor in People With Cardiovascular-Kidney-Metabolic Stage 2-3
Early add-on combination of GLP-1 receptor agonist and SGLT2 inhibitor studied in adults with cardiovascular-kidney-metabolic syndrome and r…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Study on Construction of Whole Lifecycle Cohort, Big Data Management and Clinical Prognosis of Cardio-Renal-Metabolic (CKM) Syndrome
A clinical study update describing the construction of a whole lifecycle cohort, big data management, and prognosis research for cardio-rena…